COST-EFFECTIVENESS OF DABIGATRAN ETEXILATE FOR THE SECONDARY PREVENTION OF RECURRENT DEEP VEIN THROMBOSIS AND PULMONARY EMBOLISM IN THE UNITED KINGDOM

被引：1
|
作者：
Wolowacz, S. [1 ]
Brockbank, J. [2 ]
Sunderland, T. J. [3 ]
Gonschior, A. K. [4 ]
机构：
[1] RTI Hlth Solut, Manchester, Lancs, England
[2] RTI Hlth Solut, Didsbury, England
[3] Boehringer Ingelheim GmbH & Co KG, Bracknell, Berks, England
[4] Boehringer Ingelheim GmbH & Co KG, Ingelheim, Germany
来源：
VALUE IN HEALTH | 2013年 / 16卷 / 07期
关键词：
D O I：
10.1016/j.jval.2013.08.1280
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A526 / A526
页数：1
相关论文
共 50 条
  • [1] Cost Effectiveness of the Prevention and Treatment of Deep Vein Thrombosis and Pulmonary Embolism
    David R. Anderson
    Bernie J. O’Brien
    PharmacoEconomics, 1997, 12 : 17 - 29
  • [2] Cost effectiveness of the prevention and treatment of deep vein thrombosis and pulmonary embolism
    Anderson, DR
    OBrien, BJ
    PHARMACOECONOMICS, 1997, 12 (01) : 17 - 29
  • [3] Cost-effectiveness of dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation in Taiwan
    Chang, Chia-Hsien
    Yang, Yea-Huei Kao
    Chen, Jyh-Hong
    Lin, Li-Jen
    THROMBOSIS RESEARCH, 2014, 133 (05) : 782 - 789
  • [4] Comparative Efficacy and Safety Of Dabigatran Etexilate and Rivaroxaban For The Treatment Of Deep Vein Thrombosis and Pulmonary Embolism
    Clemens, Andreas
    Abeysinghe, Shaun
    Gonschior, Ann-Katrin
    Hoesel, Volker
    Lock, Sarah
    Wolowacz, Sorrel E.
    Woods, Mathew
    Zimovetz, Evelina
    BLOOD, 2013, 122 (21)
  • [5] Cost-Effectiveness Analysis of Rivaroxaban for Treatment of Deep Vein Thrombosis and Pulmonary Embolism in Greece
    George Gourzoulidis
    Georgia Kourlaba
    John Kakisis
    Mitiadis Matsagkas
    George Giannakoulas
    Konstantinos I. Gourgoulianis
    Theodoros Vassilakopoulos
    Nikos Maniadakis
    Clinical Drug Investigation, 2017, 37 : 833 - 844
  • [6] Cost-Effectiveness Analysis of Rivaroxaban for Treatment of Deep Vein Thrombosis and Pulmonary Embolism in Greece
    Gourzoulidis, George
    Kourlaba, Georgia
    Kakisis, John
    Matsagkas, Mitiadis
    Giannakoulas, George
    Gourgoulianis, Konstantinos I.
    Vassilakopoulos, Theodoros
    Maniadakis, Nikos
    CLINICAL DRUG INVESTIGATION, 2017, 37 (09) : 833 - 844
  • [7] Cost-effectiveness of dabigatran etexilate for the prevention of stroke and systemic embolism in UK patients with atrial fibrillation
    Kansal, Anuraag R.
    Sorensen, Sonja V.
    Gani, Ray
    Robinson, Paul
    Pan, Feng
    Plumb, Jonathan M.
    Cowie, Martin R.
    HEART, 2012, 98 (07) : 573 - 578
  • [8] Cost-effectiveness of dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation: A Canadian payer perspective
    Sorensen, Sonja V.
    Kansal, Anuraag R.
    Connolly, Stuart
    Peng, Siyang
    Linnehan, John
    Bradley-Kennedy, Carole
    Plumb, Jonathan M.
    THROMBOSIS AND HAEMOSTASIS, 2011, 105 (05) : 908 - 919
  • [9] Prevention of deep vein thrombosis and pulmonary embolism
    Cooray, Ravindra
    Lake, Caroline
    ANAESTHESIA AND INTENSIVE CARE MEDICINE, 2015, 16 (09): : 457 - 461
  • [10] Prevention of deep vein thrombosis and pulmonary embolism
    Cooray, Ravindra
    Lake, Caroline
    ANAESTHESIA AND INTENSIVE CARE MEDICINE, 2018, 19 (09): : 480 - 485
12345